A drug with the SMILES N#Cc1c(Cl)c(Cl)c2nnc(-c3ccc(Br)cc3)n2c1Cl has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -15.243%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
N#Cc1c(Cl)c(Cl)c2nnc(-c3ccc(Br)cc3)n2c1Cl
N#Cc1c(Cl)c(Cl)c2nnc(-c3ccc(Br)cc3)n2c1Cl
3-(4-bromophenyl)-5,7,8-trichloro-[1,2,4]triazolo[4,3-a]pyridine-6-carbonitrile